T2 Biosystems Inc (TTOO) gains 3.81% for July 21

Equities Staff  |

T2 Biosystems Inc (NASDAQ: TTOO) shares gained 3.81%, or $0.04 per share, to close Wednesday at $1.09. After opening the day at $1.07, shares of T2 Biosystems fluctuated between $1.11 and $1.06. 2,283,296 shares traded hands a decrease from their 30 day average of 2,595,518. Wednesday's activity brought T2 Biosystems’s market cap to $163,617,739.

T2 Biosystems is headquartered in Lexington, Massachusetts..

About T2 Biosystems Inc

T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems' products include the T2Dx® Instrument, T2Candida® Panel, the T2Bacteria® Panel, the T2Resistance™ Panel, and the T2SARS-CoV-2™ Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the T2Cauris™ Panel, and T2Lyme™ Panel, as well as additional products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers, and biothreat pathogens.

Visit T2 Biosystems Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on T2 Biosystems Inc and to follow the company’s latest updates, you can visit the company’s profile page here: T2 Biosystems Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content